Inactive Instrument

Highlights THELMA Therapeutics Co., Ltd.

Equities

A015540

KR7015540008

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

EcoVive Co Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 16	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-07	CI
Tranche Update on THELMA Therapeutics Co., Ltd.'s Equity Buyback Plan announced on January 5, 2023.	23-01-06	CI
THELMA Therapeutics Co., Ltd.'s Equity Buyback announced on January 5, 2023, has closed with 195,868 shares.	23-01-05	CI
THELMA Therapeutics Co., Ltd. announces an Equity Buyback for 195,868 shares.	23-01-05	CI
THELMA Therapeutics Co., Ltd. authorizes a Buyback Plan.	23-01-04	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-16	CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Market Chatter: South Korean Regulator Rejects Thelma Therapeutics's Phase Three Trial for COVID-19 Cure	21-04-14	MT
THELMA Therapeutics Co., Ltd. agreed to acquire 30% stake in Closed Joint Stock Company NanoBrahiTek from Otkrytie LLC for KRW 20.1 billion.	20-12-30	CI
THELMA Therapeutics Co., Ltd. agreed to acquire 21% stake in Closed Joint Stock Company NanoBrahiTek from Zvezda JSC for KRW 14 billion.	20-12-30	CI
THELMA Therapeutics Co., Ltd. agreed to acquire Songjeong Pharma.	20-09-14	CI
THELMA Therapeutics Co., Ltd. cancelled the acquisition of Bitspace Co., Ltd.	20-04-01	CI
THELMA Therapeutics Co., Ltd. completed the acquisition of 27% stake in NanoBrahiTek CJSC from Zvezda JSC and Otkrytie LLC.	20-03-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights THELMA Therapeutics Co., Ltd.

Equities

A015540

KR7015540008

Highlights

Filters